The 1.5–3 μM concentrations of SERF2 that allow phase separation in the presence of rG4s are below the SERF2 concentrations present in human cells which range from ~7 μM in U2OS cells to ~23 μM in MCF7 breast cancer cells61. This evidence concerns the gene SERF2 and breast carcinoma.